Quick10K

⚲

Global Indemnity

Filings

10-Q	2020-09-30	Filed 2020-11-09
10-Q	2020-06-30	Filed 2020-08-10
10-Q	2020-03-31	Filed 2020-05-08
10-K	2019-12-31	Filed 2020-03-06
10-Q	2019-09-30	Filed 2019-11-08
10-Q	2019-06-30	Filed 2019-08-09
10-Q	2019-03-31	Filed 2019-05-10
10-K	2018-12-31	Filed 2019-03-14
10-Q	2018-09-30	Filed 2018-11-09
10-Q	2018-06-30	Filed 2018-08-09
10-Q	2018-03-31	Filed 2018-05-10
10-K	2017-12-31	Filed 2018-03-09
10-Q	2017-09-30	Filed 2017-11-09
10-Q	2017-06-30	Filed 2017-08-09
10-Q	2017-03-31	Filed 2017-05-10
10-K	2016-12-31	Filed 2017-03-10
10-Q	2016-09-30	Filed 2016-11-04
10-Q	2016-06-30	Filed 2016-08-05
10-Q	2016-03-31	Filed 2016-05-10
10-K	2015-12-31	Filed 2016-03-14
10-Q	2015-09-30	Filed 2015-11-09
10-Q	2015-06-30	Filed 2015-08-04
10-Q	2015-03-31	Filed 2015-05-11
10-K	2014-12-31	Filed 2015-03-16
10-Q	2014-09-30	Filed 2014-11-07
10-Q	2014-06-30	Filed 2014-08-08
10-Q	2014-03-31	Filed 2014-05-09
10-K	2013-12-31	Filed 2014-03-14
10-Q	2013-09-30	Filed 2013-11-06
10-Q	2013-06-30	Filed 2013-08-09
10-Q	2013-03-31	Filed 2013-05-10
10-K	2012-12-31	Filed 2013-03-15
10-Q	2012-09-30	Filed 2012-11-09
10-Q	2012-06-30	Filed 2012-08-09
10-Q	2012-03-31	Filed 2012-05-10
10-K	2011-12-31	Filed 2012-03-14
10-Q	2011-09-30	Filed 2011-11-09
10-Q	2011-06-30	Filed 2011-08-09
10-Q	2011-03-31	Filed 2011-05-10
10-K	2010-12-31	Filed 2011-03-16
10-Q	2010-09-30	Filed 2010-11-09
10-Q	2010-06-30	Filed 2010-08-09

Reports

8-K	2021-02-14	Other Events, Exhibits
8-K	2021-01-14	Officers, Exhibits
8-K	2020-12-10	Officers, Exhibits
8-K	2020-12-05	Officers
8-K	2020-12-01	Officers, Other Events, Exhibits
8-K	2020-11-09
8-K	2020-09-13
8-K	2020-08-25
8-K	2020-08-10
8-K	2020-07-15
8-K	2020-06-23
8-K	2020-06-17
8-K	2020-06-07
8-K	2020-05-29
8-K	2020-05-07
8-K	2020-03-12
8-K	2020-02-20
8-K	2020-02-09
8-K	2019-12-08
8-K	2019-12-08
8-K	2019-11-05
8-K	2019-09-16
8-K	2019-09-15
8-K	2019-08-07
8-K	2019-06-12
8-K	2019-06-02
8-K	2019-05-03
8-K	2019-03-08
8-K	2019-02-10
8-K	2018-12-02
8-K	2018-11-07
8-K	2018-09-18
8-K	2018-09-16
8-K	2018-09-16
8-K	2018-08-07
8-K	2018-06-13
8-K	2018-06-03
8-K	2018-05-08
8-K	2018-04-25
8-K	2018-03-05
8-K	2018-02-28

Global Indemnity Financials

GBLI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI)				0%	1,546	323	0	0	0	0	-854
1 800 Flowers Com (FLWS)	944	42%	13.3	6%	665	336	1,266	534	37	75	1,001
10x Genomics (TXG)	4,805	75%	-490.3	-2%	573	151	61	46	-10	-9	4,357
12 Retech (RETC)	0	32%	-0.1	-1,385%	1	20	1	0	-15	-15	1
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH)	34	0%	0.4	-5%	164	108	18	0	-8	-8	-3
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	19	23	27	7	-3	-1	3
1895 Bancorp of Wisconsin (BCOW)	46,153		12,508.1	-0%	441	383	0	0	-0	4	46,142
1st Constitution Bancorp (FCCY)	165	0%	4.4	1%	1,343	1,204	0	0	14	33	144
1st Franklin Financial (FFC)	4		-0.6	7%	905	645	0	0	62	80	-46
24 7 Kid Doc (TVMD)
1st Source (SRCE)	1,200		7.9	1%	6,691	5,858	0	0	70	136	1,073
2050 Motors (ETFM)	0		-0.2	-166,272,400%	0	2	0	0	-2	-2	0
21Vianet Group (VNET)	6,005			0%	11,151	5,788	0	0	0	0	3,344
22nd Century (XXII)	302	1%	-14.1	-36%	62	7	26	0	-22	-21	302
1Life Healthcare (ONEM)


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	106	93	176	101	77	108	104	69	111	116	105	99	118	67	114	67	66	147	67	47	71	64	75	128	96	60	74	74	47	41	99	38	56	78
Accounts Receivable
Inventory
PP&E
Assets	2,239	2,133	2,076	2,081	1,992	1,964	1,904	1,918	1,915	1,918	1,912	1,924	1,978	1,880	1,930	2,274	2,260	2,319	1,957	1,967	2,006	1,982	1,973	2,072	2,104	2,131	2,002	1,964	1,982	1,958	1,960	1,985	2,015	2,084
Accounts Payable
Long-Term Debt	121	103	103	103	103	85	85	85	85	21								296	172	167	175	176	163	298	301	307	303	293	294	289	289	301	300	312
Liabilities	1,295	1,255	1,234	1,221	1,196	1,157	1,097	1,090	1,091	1,080	1,038	1,043	1,081	982	1,022	1,347	1,329	1,397	1,207	1,201	1,235	1,199	1,175	1,257	1,277	1,307	1,283	1,260	1,279	1,256	1,331	1,317	1,321	1,377
Stockholders' Equity	943	877	842	859	795	807	807	828	824	839	873	881	897	898	908	927	931	922	750	766	771	782	798	815	828	824	718	704	702	702	629	668	695	707


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	101	91	79	77	71	73	71	72	71	75	101	75	114	76	-265	133	145	124	136	125	122	138	150	124	117	120	124	120	128	138		140	146	142
Cost of Revenue
Gross Profit
R&D
SG&A
Tax	-2	0	-4	-3	-2	2	-2	-0	-0	-2	3	-2	12	-2	0	-4	-1	-6	2	-5	-6	1	8	-3	-2	-8	13	-1	-1	-3		4	1	-0
Net Income	4	-34	-24	11	55	10	4	12	11	7	34	9	35	10	11	7	11	-4	27	7	-5	10	38	12	13	-9	-23	6	22	4	-73	20	15	7


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		-5	-9	-18	-5	-3	32	-10	4	6	-4	-11		6	-5	6	13	-20	5	-10	14	-13	-15	-15	10	-8	-10	41		-13		-23	20	49
Cash Investing		10	121	-48	47	58	8	-25	38	-2	-21	5		22	-115	-30	6	-4	225	-3	2	8	36	-64	-41	-31	112	-29		15		-40	4	-32
Cash Financing		-18	-29	-9	-66	-24	84	-0	-0	1	14	-0		-80	38	32	-20	105	-310	-6	7	-1	-10	132	-0	3	-87	-14		-9		1	-6	5